Click for best price
mRNA Cancer Vaccines Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 144.5 million
|
Forecast Market size by 2029 |
US$ 465.2 million
|
| Growth Rate |
CAGR of 18.2% |
Number of Pages |
65 Pages |
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
This report aims to provide a comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics. This report contains market size and forecasts of mRNA Cancer Vaccines and Therapeutics in global, including the following market information:
Global mRNA Cancer Vaccines and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global mRNA Cancer Vaccines and Therapeutics market was valued at US$ 144.5 million in 2022 and is projected to reach US$ 465.2 million by 2029, at a CAGR of 18.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
We surveyed the mRNA Cancer Vaccines and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Cancer Vaccines and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, by Type, 2022 (%)
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Global mRNA Cancer Vaccines and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Cancer
Others
Global mRNA Cancer Vaccines and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Cancer Vaccines and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies mRNA Cancer Vaccines and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Cancer Vaccines and Therapeutics, market overview.
Chapter 2: Global mRNA Cancer Vaccines and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of mRNA Cancer Vaccines and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Cancer Vaccines and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
mRNA Cancer Vaccines and Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 144.5 million
|
| Forecast Market size by 2029 |
US$ 465.2 million
|
| Growth Rate |
CAGR of 18.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 mRNA Cancer Vaccines and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Cancer Vaccines and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Cancer Vaccines and Therapeutics Overall Market Size
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size: 2022 VS 2029
2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.2 Top Global mRNA Cancer Vaccines and Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Cancer Vaccines and Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Adeno Carcinomas
4.1.3 Mucinous Carcinomas
4.1.4 Adenosquamous Carcinomas
4.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.1.4 Others
5.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029
6.3.2 US mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029
6.4.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.3 France mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.4 U.K. mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.5 Italy mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.6 Russia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.4.8 Benelux mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029
6.5.2 China mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.5.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.5.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.5.6 India mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029
6.6.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.6.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029
6.7.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.7.3 Israel mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
6.7.5 UAE mRNA Cancer Vaccines and Therapeutics Market Size, 2018-2029
7 mRNA Cancer Vaccines and Therapeutics Companies Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. mRNA Cancer Vaccines and Therapeutics Market Opportunities & Trends in Global Market
Table 2. mRNA Cancer Vaccines and Therapeutics Market Drivers in Global Market
Table 3. mRNA Cancer Vaccines and Therapeutics Market Restraints in Global Market
Table 4. Key Players of mRNA Cancer Vaccines and Therapeutics in Global Market
Table 5. Top mRNA Cancer Vaccines and Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Moderna Therapeutics Company Summary
Table 31. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 32. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Moderna Therapeutics Key News & Latest Developments
Table 34. CureVac Company Summary
Table 35. CureVac mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 36. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. CureVac Key News & Latest Developments
Table 38. Translate Bio Company Summary
Table 39. Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 40. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Translate Bio Key News & Latest Developments
Table 42. BioNTech Company Summary
Table 43. BioNTech mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 44. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. BioNTech Key News & Latest Developments
Table 46. Sangamo Therapeutics Company Summary
Table 47. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 48. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Sangamo Therapeutics Key News & Latest Developments
Table 50. Argos Therapeutics Company Summary
Table 51. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 52. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Argos Therapeutics Key News & Latest Developments
Table 54. In-Cell-Art Company Summary
Table 55. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 56. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. In-Cell-Art Key News & Latest Developments
Table 58. eTheRNA Company Summary
Table 59. eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 60. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. eTheRNA Key News & Latest Developments
Table 62. Ethris Company Summary
Table 63. Ethris mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 64. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Ethris Key News & Latest Developments
Table 66. Tiba Biotechnology Company Summary
Table 67. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 68. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Tiba Biotechnology Key News & Latest Developments
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Segment by Type in 2022
Figure 2. mRNA Cancer Vaccines and Therapeutics Segment by Application in 2022
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2022
Figure 8. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 16. US mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 28. China mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CureVac mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ethris mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
